The cardiopulmonary bypass systems market is expected to grow at a compound annual growth rate (CAGR) of 3.2% over the course of the forecast period, from US$ 197.3 million in 2023 to US$ 270.9 million in 2033.
It is predicted that the need for cardiopulmonary bypass machines will be driven by the increased costs associated with treating major illnesses including cardiac disorders. However, the adoption of these devices is expected to be hindered by unfavorable side effects resulting from bypass surgeries. On the other hand, it is anticipated that the rapid advancement of technology and the rise in surgical procedures will spur market growth and present market participants with innovative possibilities.
Navigate Future Trends With a Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5855
Supporting Heart Health: Cardiopulmonary Bypass Systems Play a Vital Role
The global cardiopulmonary bypass system market is experiencing continued growth, driven by the increasing need for effective tools in cardiac surgery. Cardiopulmonary bypass systems play a critical role in open-heart surgery by temporarily taking over the functions of the heart and lungs, allowing surgeons to operate on a still heart.
Market Growth Fueled by Multiple Factors:
Several factors are contributing to the growth of the cardiopulmonary bypass system market:
- Increased Focus on Cardiac Care: Rising healthcare expenditure directed towards combating heart disease, a leading global health concern, is creating a greater demand for advanced cardiac surgical procedures.
- Technological Advancements: The market is continuously evolving with the development of innovative bypass systems. Roller pumps, for example, are gaining traction due to their affordability, ease of use, and reliable flow management.
- Expanding Surgical Needs: The growing number of lung transplant procedures, particularly en-bloc double-lung transplants, is driving the demand for cardiopulmonary bypass systems to support these complex surgeries.
Our Methodology Overview:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5855
Key Takeaways:
- The global cardiopulmonary bypass system market is expected to reach US$270.9 million by 2033, reflecting a rise from US$197.3 million in 2023.
- This growth is projected at a steady compound annual growth rate (CAGR) of 3.2% throughout the forecast period.
- Rising healthcare spending on cardiac procedures and advancements in technology are key drivers for market expansion.
The Cardiopulmonary Bypass System Market:
- Minnetronix Inc.
- Transonic
- MAQUET Holding B.V. & Co. KG.
- Getinge AB
- Terumo Corporation
- MicroPort Scientific Corporation
- Xenios AG
- Nipro Corporation
- Eurosets Srl
- OriGen Biomedical
- Thoratec Corporation
- Tianjin Medical
- Olympus Corporation
- Haemonetics Corporation
Some Recent Developments in the Cardiopulmonary Bypass System Market are:
- In June 2014, Sorin Group celebrated the delivery of its 10,000th heart-lung machine (S5 heart-lung machine) to Brigham and Women’s Hospital, Boston, MA, USA. Thuse achieved an exciting milestone that reflects the tremendous trust and collaborative partnership with their customers worldwide.
- In October 2021, MicroPort acquired 100% of the equity held by existing shareholders of Hemovent GmbH. Hemovent specializes in the development of ground-breaking Extracorporeal Life Support (ECLS) systems.
- In February 2022, Getinge acquired 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical’s offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor and delivery episodes and critical care support, including ECMO Therapy.
- In April 2022, LivaNova initiated the targeted commercial launch of Essenz™. Patient Monitor for cardiopulmonary bypass procedures. The transformative monitoring system uses a patient-tailored approach to improve clinical efficiency and quality of patient care during cardiopulmonary bypass (CPB) procedures.
- In January 2021, Eurosets announced the full commercial release (out of the USA) of its novel ECMOlife system for Extracorporeal Life Support (ECLS). ECMOlife expands Eurosets’ portfolio to temporarily support patients in different therapeutic areas, including Extracorporeal Membrane Oxygenation (ECMO) and Mechanical Circulatory Support (MCS).
Key Segments Profiled in the Cardiopulmonary Bypass System Industry Survey Report:
By Product Type:
- Conventional
- Mini
By Modality:
- Standalone
- Portable
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Research Centers
By Region:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa
- Europe
Act Now for Detailed Market Analysis: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/5855
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube